Literature DB >> 8152906

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.

F Vikhanskaya1, E Erba, M D'Incalci, M Broggini.   

Abstract

Utilizing a temperature sensitive p53 mutant (pLTRp53cGval135) which expresses mutant p53 at 37 degrees C and a wild-type like p53 at 32 degrees C, we transfected a human ovarian cancer cell line (SKOV3) which does not express endogenous p53. Among the different clones obtained, we selected three clones. Two were obtained from simultaneous transfection of p53 and neomycin resistance expression plasmids (SK23a and SK9), the other was obtained from transfection experiments utilizing the neomycin resistance gene only (SKN). Introduction of mutant p53 did not alter the morphology or growth characteristics of this ovarian cancer cell line. Upon shifting to the permissive temperature, a dramatic change in morphology and growth rate was observed in SK23a and SK9 cells that is associated with the presence of a wild-type like p53. SKN and SKOV3 cells maintained at 32 degrees C did not change morphology and only slightly reduced proliferation. Both SK23a and SK9 cells did not show evidence of apoptosis when measured up to 72 hours of maintenance at 32 degrees C. In contrast to what observed in other cell lines, SK23a and SK9 cells maintained at 32 degrees C were not blocked in G1, but they were accumulated in G2-M. This accumulation was transient and could be due either to a blockade or to a delay in the G2 progression. No down-regulation of c-myc was observed in p53 expressing clones when shifted to the permissive temperature. In these conditions gadd45 mRNA expression was highly stimulated in SK9 and SK23a cells but not in SKN cells. In both clones Gas1 mRNA was not detected either at 37 degrees C or 32 degrees C. This system represents a new and useful model for studying the effect of the absence of p53 (SKOV3 or SKN), presence of mutated p53 (SK23a and SK9 kept at 37 degrees C) or wild type p53 (SK23a and SK9 kept at 32 degrees C) on the mechanism of response of cancer cells to DNA damaging agents.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152906      PMCID: PMC307923          DOI: 10.1093/nar/22.6.1012

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  51 in total

1.  Isolation and characterization of DNA sequences that are specifically bound by wild-type p53 protein.

Authors:  O Foord; N Navot; V Rotter
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

2.  p53-mediated cell death: relationship to cell cycle control.

Authors:  E Yonish-Rouach; D Grunwald; S Wilder; A Kimchi; E May; J J Lawrence; P May; M Oren
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

3.  Overproduction of Rb protein after the G1/S boundary causes G2 arrest.

Authors:  V Karantza; A Maroo; D Fay; J M Sedivy
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

4.  Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.

Authors:  J J Ryan; R Danish; C A Gottlieb; M F Clarke
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

5.  Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.

Authors:  Y Yaginuma; H Westphal
Journal:  Cancer Res       Date:  1992-08-01       Impact factor: 12.701

6.  p53 mutation is a common genetic event in ovarian carcinoma.

Authors:  B J Milner; L A Allan; D M Eccles; H C Kitchener; R C Leonard; K F Kelly; D E Parkin; N E Haites
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

Review 7.  p53: the ultimate tumor suppressor gene?

Authors:  M Oren
Journal:  FASEB J       Date:  1992-10       Impact factor: 5.191

8.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  Wild-type p53 binds to the TATA-binding protein and represses transcription.

Authors:  E Seto; A Usheva; G P Zambetti; J Momand; N Horikoshi; R Weinmann; A J Levine; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Interaction of heat-shock protein 70 with p53 translated in vitro: evidence for interaction with dimeric p53 and for a role in the regulation of p53 conformation.

Authors:  P Hainaut; J Milner
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  16 in total

1.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  p53 regulates the minimal promoter of the human topoisomerase IIalpha gene.

Authors:  M I Sandri; R J Isaacs; W M Ongkeko; A L Harris; I D Hickson; M Broggini; F Vikhanskaya
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

3.  Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter.

Authors:  A M Metcalfe; R M Dixon; G K Radda
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

Review 4.  Delivery of cell cycle genes to block astrocytoma growth.

Authors:  J Fueyo; C Gomez-Manzano; T J Liu; W K Yung
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  Aberrant TGFβ/SMAD4 signaling contributes to epigenetic silencing of a putative tumor suppressor, RunX1T1 in ovarian cancer.

Authors:  Kun-Tu Yeh; Tze-Ho Chen; Hui-Wen Yang; Jian-Liang Chou; Lin-Yu Chen; Chia-Ming Yeh; Yu-Hsin Chen; Ru-Inn Lin; Her-Young Su; Gary C W Chen; Daniel E Deatherage; Yi-Wen Huang; Pearlly S Yan; Huey-Jen Lin; Kenneth P Nephew; Tim H-M Huang; Hung-Cheng Lai; Michael W Y Chan
Journal:  Epigenetics       Date:  2011-06-01       Impact factor: 4.528

6.  p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.

Authors:  F Vikhanskaya; M D'Incalci; M Broggini
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

7.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5.

Authors:  Xingguo Song; Xia Zhang; Xiaoyan Wang; Faliang Zhu; Chun Guo; Qun Wang; Yongyu Shi; Jianing Wang; Youhai Chen; Lining Zhang
Journal:  Autophagy       Date:  2013-03-13       Impact factor: 16.016

9.  Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.

Authors:  M Trepel; P Groscurth; U Malipiero; E Gulbins; J Dichgans; M Weller
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

10.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Authors:  M L Agarwal; A Agarwal; W R Taylor; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.